PantoniL. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol2010; 9:689–701.
2.
WardlawJMSmithCDichgansM. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol2013; 12:483–97.
3.
WardlawJMSmithEEBiesselsGJ. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol2013; 12:822–38.
4.
CharidimouAFoxZWerringDJSongM. Mapping the landscape of cerebral amyloid angiopathy research: an informetric analysis perspective. J Neurol Neurosurg Psychiatry2015. DOI: 10.1136/jnnp-2015-310690.
HughesMEPeelerJHogeneschJBTrojanowskiJQ. The growth and impact of Alzheimer disease centers as measured by social network analysis. JAMA neurology2014; 71:412–20.
7.
SorensenAA. Alzheimer's disease research: scientific productivity and impact of the top 100 investigators in the field. Journal of Alzheimer's disease: JAD2009; 16:451–65.
8.
SongMHeoGLeeD. Identifying the landscape of Alzheimer's disease research with network and content analysis. Scientometrics2014; 102:1–23.